 |
AgeneBio
Last updated: May 01, 2024
Jerry McLaughlin, President and CEO
Country: USA | Funding: $14.4M (+)
Website: http://www.agenebio.com/
AgeneBio is developing innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function.
Website: http://www.agenebio.com/
AgeneBio is developing innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function.
